Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Short Bowel Syndrome - Overview
Short Bowel Syndrome - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Short Bowel Syndrome - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Short Bowel Syndrome - Companies Involved in Therapeutics Development

9 Meters Biopharma Inc
Applied Molecular Transport Inc
enGene Inc
Hanmi Pharmaceuticals Co Ltd
Huons Global Co Ltd
Micelle BioPharma Inc
po Pharmaceuticals Inc
OPKO Health Inc
PhaseBio Pharmaceuticals Inc
Surrozen Inc
Tasly Pharmaceutical Group Co Ltd
VectivBio Holding AG
Worphmed Srl
Zealand Pharma AS
Short Bowel Syndrome - Drug Profiles
apraglutide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Bispecific Monoclol Antibody for Short Bowel Syndrome - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
crofelemer DR - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
dapiglutide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Fusion Protein to Agonize GLP2R for Short Bowel Syndrome - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Fusion Protein to Agonize GLP2R for Short Bowel Syndrome - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy for Short Bowel Syndrome - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
glepaglutide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GXG-8 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HL-06 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HM-15912 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
melatonin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MOD-1501 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NB-1002 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SC-403 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
vuroletide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Short Bowel Syndrome - Dormant Projects
Short Bowel Syndrome - Discontinued Products
Short Bowel Syndrome - Product Development Milestones
Featured News & Press Releases
Oct 26, 2021: 9 Meters Biopharma presents pharmacokinetic data from phase 1b/2a study with Vuroletide, currently in phase 2 for short bowel syndrome, at the American College of Gastroenterology (ACG) 2021 Annual Scientific Meeting
Oct 19, 2021: 9 Meters Biopharma to present data on therapeutic candidate in short bowel syndrome at the American College of Gastroenterology (ACG) 2021 Annual Scientific Meeting
Sep 16, 2021: VectivBio announces upcoming investor events
Sep 15, 2021: Orphan Drug Desigtion application submitted by Jaguar Health subsidiary for crofelemer for short bowel syndrome with intestil failure accepted for review by European Medicines Agency
Sep 13, 2021: Providing innovative treatment options for patients with intractable rare disease short bowel syndrome
Sep 09, 2021: Zealand Pharma presents data at 2021 ESPEN Virtual Congress Demonstrating Dose-dependent Effects of Glepaglutide in both small and large intestines of animal models - in contrast to short-acting GLP-2
Aug 19, 2021: Zealand Pharma announces first patient dosed in EASE-SBS 4 phase 3b trial assessing glepaglutide in patients with short bowel syndrome
Jun 29, 2021: Zealand Pharma to present data on glepaglutide at the 17th Congress of the Intestil Rehabilitation and Transplantation Association (CIRTA)
Jun 15, 2021: VectivBio announces first patient dosed in metabolic balance study of apraglutide in colon-in-continuity patients with short bowel syndrome with intestil failure
Jun 14, 2021: 9 Meters announces initiation of phase 2 VIBRANT study of Vuroletide for short bowel syndrome
May 17, 2021: 9 Meters Biopharma receives USAN approval to use the desigted nonproprietary me Vuroletide for its long-acting GLP-1 agonist for short bowel syndrome
Apr 07, 2021: Hanmi’s short bowel syndrome drug gets FDA fast-track status
Mar 15, 2021: 9 Meters Biopharma hosting key opinion leader webir on short bowel syndrome and NM-002 program update
Feb 03, 2021: VectivBio announces first patient dosed in pivotal phase 3 trial of Apraglutide for the treatment of short bowel syndrome
Feb 01, 2021: 9 Meters Biopharma announces Research & Development Day on short bowel syndrome
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Short Bowel Syndrome, 2021
Number of Products under Development by Companies, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Short Bowel Syndrome, 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Short Bowel Syndrome - Pipeline by 9 Meters Biopharma Inc, 2021
Short Bowel Syndrome - Pipeline by Applied Molecular Transport Inc, 2021
Short Bowel Syndrome - Pipeline by enGene Inc, 2021
Short Bowel Syndrome - Pipeline by Hanmi Pharmaceuticals Co Ltd, 2021
Short Bowel Syndrome - Pipeline by Huons Global Co Ltd, 2021
Short Bowel Syndrome - Pipeline by Micelle BioPharma Inc, 2021
Short Bowel Syndrome - Pipeline by Napo Pharmaceuticals Inc, 2021
Short Bowel Syndrome - Pipeline by OPKO Health Inc, 2021
Short Bowel Syndrome - Pipeline by PhaseBio Pharmaceuticals Inc, 2021
Short Bowel Syndrome - Pipeline by Surrozen Inc, 2021
Short Bowel Syndrome - Pipeline by Tasly Pharmaceutical Group Co Ltd, 2021
Short Bowel Syndrome - Pipeline by VectivBio Holding AG, 2021
Short Bowel Syndrome - Pipeline by Worphmed Srl, 2021
Short Bowel Syndrome - Pipeline by Zealand Pharma AS, 2021
Short Bowel Syndrome - Dormant Projects, 2021
Short Bowel Syndrome - Discontinued Products, 2021